Memorial Sloan Kettering Cancer Center State-of-the-Art in Benign Hematology, Hemostasis, and Thrombosis 2025

Memorial Sloan Kettering Cancer Center State-of-the-Art in Benign Hematology, Hemostasis, and Thrombosis 2025

Hematology, Oncology

Overview

💎 Lifetime Access · Benign Hematology + Hemostasis/Thrombosis · Emerging Therapeutics Memorial Sloan Kettering Cancer Center—State-of-the-Art in Benign Hematology, Hemostasis, and Thrombosis 2025 A one-day, in-person MSKCC symposium delivering a state-of-the-art update in benign hematology, with a strong emphasis on hemostasis, thrombosis, and emerging therapeutic strategies. Designed for clinicians managing complex thrombotic and bleeding disorders in real-world, high-acuity settings.

Factor XI Inhibitors Anticomplement Therapies PNH & Complement-Mediated Hemolysis Cancer-Associated Thrombosis Immunotherapy Complications ITP & TMA Updates ✅ Access Note: After purchase, access is provided via Google Drive with unlimited access. All files are downloadable for offline review (including the online.

Course Details

• Price: $75.00
• Access Type: Lifetime
• Delivery Method: Google Drive Link, Offline
• Content Format: QBank

What's Included

• Video lectures and recordings
• PDF study materials and resources
• Board exam preparation materials

Target Audience

• Fellows
• Physician
• Students
• Nurses
• NP

Key Features

• Expert-led instruction and content
• Comprehensive coverage of topic area
• Flexible learning schedule
• Lifetime access to all materials